Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Community social media sites massively more popular than those run by pharma

PwC study finds communities’ Facebook, Twitter and YouTube use shows 24 times more activity than the corresponding use of social media by health industry companies

Facebook pages, Twitter accounts and YouTube channels run by online consumer communities showed 24 times more activity than those run by health industry companies in the US, according to PwC.

During February 2012, the consultants tracked the social media activity of healthcare companies, looking at providers, insurers and pharmaceutical companies, and compared it to online consumer communities to create a 'week in the life of social health'.

Community sites were found to have the largest numbers of members and interactions – by both community moderators and members. They were also active at the weekend and were mostly driven by their members.

In contrast, healthcare companies had minimal activity over the weekend, but industry sites did still attract new members (on average more than 100 new members engaged with each company throughout the week).

“The interactions that did take place [on industry sites] were high-quality touchpoints between organisations and consumers, where they shared an educational resource or resolved a customer service issue," PwC said in its report Social Media Likes Healthcare: From Marketing To Social Business.

Despite concerns by industry leaders that social media triggers negative conversation, more than 80 per cent of interactions were neutral and only 5 per cent were negative.

The report also surveyed over 1,000 people and found that one third used social media for health matters.

19th April 2012

From: Marketing

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...
Behaviour change through medical education: How can we turn aspiration into reality?
Practical, evidence-based insights into a CME process that aims to effect measurable behaviour change...

Infographics